BALTIMORE, MD, September 14, 2021 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Ru Chih Chow Huang with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Ds. Huang celebrates many years' experience in her professional network, and has been noted for achievements, leadership qualities, and the credentials and successes she has accrued in her field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Ru Chih Chow Huang is an influential molecular biology educator who has been serving Johns Hopkins University in Baltimore for the past 56 years. Hired by the university as an assistant professor of molecular biology in 1965, she was promoted to associate professor in 1977 and has flourished as a full professor since 1975. In 2011, Dr. Huang became Inaugural Dr. William McElroy Honorary Research Professor at Johns Hopkins. At the inception of her career in 1960, she was a postdoctoral fellow at the California Institute of Technology.
Dr. Huang's early work addresses many critical discoveries on the function of chromosomal proteins, messenger RNA and RNA synthesizing enzyme, as the RNA polymerase represent the major aspect of her earlier contributions to the field of molecular biology. Her more recent research focuses on the understanding of viral replication and oncogenic development in humans. According to Dr. Kolata, "...when looking at the reality of cancer closely, it appears that one of the major obstacles for anticancer treatment is tumor recurrence. The cancers that develop after the tumor remission period are usually very aggressive and defy most anticancer treatments. There are many reasons to believe that in the conversion from tumor dormancy to fast growth, cancer cells in micro-metastasis lesions play a crucial role. Thus, a new direction in cancer drug development has been in major demand for years." (New York Times, Front Page – April 24th, 2009).
Terameprocol (M+N, EMI421, Mol Wt. 358) is a promising new drug for treating human cancers. It was originally discovered by Dr. Huang's laboratory at Johns Hopkins University. Terameprocol when used in combination with Rapamycin (Rap) or Rottlerin and either Etoposide (Etop) or Ly292004, was able to synergistically induce rapid cell death in prostate, colon, pancreas, breast and brain cancer cells in culture and eliminate LNCap prostate cancer cell explants, orthotopic LNCaP-derived prostate tumors and metastasis in mice. In this study, 100% of the treated animals were cured of cancer and lived in good health. Since Terameprocol, Rapamycin and Etoposide have already been approved for human patient use, clinical trials with these combinations should be applicable. Essentially all cancer patients could benefit from Terameprocol treatments. Patients with long term survival periods and minimal metastasis as expected are following these types of treatment plans.
Alongside her career responsibilities, Dr. Huang sat on the board of directors of the Institute of Molecular Biology, Academia Sinica, in Taiwan from 1987 to 1988 and served as chair of the board of science counselors with the National Institute on Aging and National Institutes of Health from 1980 to 1984. Met with achievements throughout her career, she attributes her success to her three mentors: Maynard Hale at Virginia polyechnic Institute and State lJniversity, Joe Varner at The Ohio State University and James Bonner at the California Institute of Technology.
During her tenure in academia, Dt. Huang was afforded opportunities to work with PhD students and postdoctoral fellows at Johns Hopkins. These opportunities provided her with a chance to accomplish an important anti-cancer study and fulfill one of her long-term goals: preventing, treating and halting the spread of human malignancies, in addition to her ground-breaking research in the field of Chromatin Biology, as evident by her paper in Citation Classics Number 12; March 20, 1978 (Huang R C & Bonner J. Histone, a suppressor of chromosomal RNA synthesis. PNAS US 48: 1216-22, 1962).
EDUCATION HIGHLIGHTS
Dr. Huang earned a Bachelor of Science from National Taiwan University in 1953. She went on to attain a Master of Sciences from Virginia Polytechnic Institute and State University in 1956 and Doctor of Philosophy from The Ohio State University in 1960.
AWARD HIGHLIGHTS
Notably, Dr. Huang was honored as Woman of the Year by the American Biographical Institute in 20l1, as well as the recipient of the Outstanding Asian-American Science Award and American Women in Science Award in 1985. Recognized as one of the Nation's Most Respected Teachers from 2003-2005, she was also granted a visiting chair professorship from National Central University from 2008-2012 and University Chair Profess-or, National Chiao Tung University, Taiwan. Likewise, Dr. Huang was selected for inclusion in the 24th edition of Who's Who in the East and the 50th edition of Who's Who in America.
Among her many impressive achievements over the years, Dr. Huang fondly recalls her many published papers, including her ground-breaking research in the field of Chromatin Biology in 1962, which she considers to have been the most important discoveries of her career. She is also incredibly proud of her current research on the origins of cancer, as she believes her promising and hopeful findings will help to better prevent cancer and its progression. Grateful for the support of her stellar colleagues and her mentors. Dr. Huang attributes her success to her faith in God, her humility and her ability to look at the bigger picture when it comes to her discipline.
Harboring a lifelong interest in research and human health, Dr. Huang has been equally devoted to her amazing family as she ensures a proper and efficient balance for her professional and personal life. Looking toward the future, she hopes that her research and the mutual beneficial interests in science and medicine will help different countries find common ground and peace with one another, including with the COVID-I9 pandemic. Dr. Huang also hopes that her published work will continue to make an impact through additional publications in periodicals and newsletters.
About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #